for February 2019
A truly difficult challenge in primary care, hospital medicine, ID, and abx stewardship is determining which elderly patients with positive urine cultures need treatment. Fascinating study in @bmj_latest https://t.co/oqFr2WzueH
— Paul Sax (@PaulSaxMD) February 28, 2019
NEW 🔥 Prospective 🇬🇷observational study @BSACandJAC an oral regimen of fosfomycin 3g q24h for 1 week followed by 3 g q48h for the treatment of MDR chronic bacterial prostatitis. #antibioticsteward https://t.co/IlkZSwrO5z pic.twitter.com/XVHDFjU5qh
— Antibiotic Steward (@ABsteward) February 23, 2019
NEW🔥 in AAC Antibiotic treatment duration for bacteremia due to Enterobacteriaceae:A systematic review&meta-analysis.
— Antibiotic Steward (@ABsteward) February 25, 2019
No differences in clinical outcomes between short and long courses
Authors conclusion:Further well-designed studies are needed🤔https://t.co/VeCuGzxazd pic.twitter.com/KAw0GYO8IR
🔥🔥NEW! January is over, did you miss anything? Here is our monthly top NEW articles in the fields of antimicrobial stewardship & infectious Diseases from @IDstewardship & I 📲https://t.co/m8xyIJIpCA pic.twitter.com/v60p2Bvp9q
— Antibiotic Steward (@ABsteward) February 7, 2019
Call for applications for the creation of new junior groups (G5s): This #call for proposals focuses on the 3 topics:
— Institut Pasteur (@institutpasteur) February 8, 2019
▪ Emerging infectious diseases
▪ Antimicrobial resistance
▪ Brain connectivity and neurodegenerative diseases. https://t.co/jWXe21Q2l0
NEW 🔥 Review article in the Annals of Pharmacotherapy by @SIDPharm Dr. Alan Gross :Vancomycin Versus Metronidazole for Nonsevere Clostridioides difficile Infection: Are the Data Adequate to Change Practice? https://t.co/bnRf7rSr53 pic.twitter.com/HvBOhFSMR3
— Antibiotic Steward (@ABsteward) February 8, 2019
New 🔥 Review article by Dr. Pranita Tamma in @ICHEJournal Integrating bedside nurses into antibiotic stewardship: A practical approach https://t.co/ayKJbh2YQw pic.twitter.com/ehp7Vn4tm9
— Antibiotic Steward (@ABsteward) February 21, 2019
NEW 🔥 in @ARICJournal by @DilipNathwani et Al
— Antibiotic Steward (@ABsteward) February 14, 2019
Value of hospital antimicrobial stewardship programs: a systematic review. https://t.co/B2nt3qjt1h pic.twitter.com/DTqHq2pp6k
Finding: measles predisposes children to all other infectious diseases for up to a few years; if you vaccinate your children against the measles they can avoid other infectious diseases as well https://t.co/awY6HyS41Q
— Rebeccah Heinrichs (@RLHeinrichs) February 10, 2019
NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye
— Antibiotic Steward (@ABsteward) February 2, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Recommendations from @ACCP, @ESCMID, @IDSAInfo, @ISAP_org, and @SIDPharm. @SCCM https://t.co/QXKkYamVj6 pic.twitter.com/f5sH0pD2vb
NEW 🔥🔥 by the expert in antibiotic pk pd @jasonroberts_pk in @BSACandJAC Defining optimal dosing of ciprofloxacin in patients with septic shock. Pathogens with higher MICs or in patients with ARC, doses may have to be increased[600mgq8h].
— Antibiotic Steward (@ABsteward) February 27, 2019
#JACnews https://t.co/X9h97WRNOW pic.twitter.com/e7bUzhbSSd
Reduction of antibiotic consumption will not be sufficient to control AMR because the spread of resistant strains and resistance genes seems to be the dominant contributing factor https://t.co/sPtjx1Jq4O
— Laura Piddock (@LauraPiddock) February 16, 2019
Pathogen sequencing is "transforming the public health approach to infectious diseases, as well as the treatment of individual patients."https://t.co/S14gmXCbPL @JAMA_current @CDCgov @CDC_Genomics @CDC_AMD by @martagwinn @dmaccannell G Armstrong @nanopore pic.twitter.com/igaablYabw
— Eric Topol (@EricTopol) February 17, 2019
A new study in #ClinInfectDis found hospitals with antibiotic stewardship programs reduced use of fluoroquinolones during hospitalization, but not at hospital discharge. #AMR @medpagetoday https://t.co/hhZOVHXdpB
— IDSA (@IDSAInfo) February 17, 2019
NEW 🔥🔥 @IDpharmresearch in OFID Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections treated with Vancomycin. Vancomycin plus beta-lactams debate continues.🤔 https://t.co/SRErFHnxWA pic.twitter.com/zw1UQrje55
— Antibiotic Steward (@ABsteward) February 27, 2019
NEW🔥 @DrDrayMBA @blandman19 @MeganARech @ErinMcCreary @Tribidibidy @klusardi41 @JACCPJournal Perceptions &Practices for B‐Lactam Antibiotic Dosing Administration & Monitoring in Critically Ill Patients:Current Views and Use Among CC and ID Pharmacists. https://t.co/ay7W9HIeL2 pic.twitter.com/yscDgD7gMp
— Antibiotic Steward (@ABsteward) February 14, 2019
NEW🔥 🔥in OFID by @SIDPharm @ae_gross
— Antibiotic Steward (@ABsteward) February 13, 2019
Successful implementation of an antibiotic stewardship program in an academic dental practice.
73% ⬇️ in antibiotic prescribing after implementation of a dental ASP. https://t.co/1QK7vCOo3j pic.twitter.com/hoAsdLOhHT
NEW🔥Cluster RCT in @bmj_latest : An antimicrobial stewardship intervention delivered remotely into practices and integrated into routine care delivery was associated with a 12% reduction in antibiotic prescriptions for RTI. REDUCE RCT #idprn https://t.co/dEnVZfS3MJ pic.twitter.com/8NmBg23MTH
— Antibiotic Steward (@ABsteward) February 13, 2019
Excited to share our article on nursing engagement in #AntimicrobialStewardship in @AJICJournal, available for free via this link: https://t.co/wBGDrCxGBi pic.twitter.com/KMcEWkYfHo
— Mike Stevens (@Dr_Mike_Stevens) February 27, 2019
New comment in the March issue of @TheLancetInfDis> Twitter to engage, educate, and advocate for global antibiotic stewardship and antimicrobial resistance https://t.co/U1naypLS3h @idpharmd @IDroadrunner @SouthAfricanASP @DilipNathwani @mtosterholm #AMR
— onisillos sekkides 🦠 (@onisillos) February 28, 2019
NEW🔥 in CID @Doaa_Aljefri/@IDPharmacometrx/@MPostelnick
— Antibiotic Steward (@ABsteward) February 1, 2019
Vancomycin Area under the Curve and Acute Kidney Injury: A Meta-analysis. https://t.co/tiojuDFPy3 pic.twitter.com/LCZqhFpWCN
NEW🔥 in OFID by @Bruce_M_Jones and @blandman19
— Antibiotic Steward (@ABsteward) February 27, 2019
Clinical and Economic Outcomes of Penicillin Skin Testing as an Antimicrobial Stewardship Initiative in a Community Health System. Great work.👏 Cc @BBookstaver_USC @KimberlyBlumen1 https://t.co/MpejWZyEjB pic.twitter.com/Q74uGFW7Sz
Like infectious diseases, ideas in the academic world are contagious. Computer scientists used an epidemiological model to simulate how ideas move from one academic institution to another. https://t.co/BiksjvlTSS
— Scientific American (@sciam) February 1, 2019
Found an interesting article about measles (rubela). It's one of the most infectious diseases in the world, and it's not so much a problem anymore thanks to vaccination.
— Kamal Amzan (@DrKamalAmzan) February 4, 2019
Let's hope that it will stay that way.
8 things everybody should know about measles: https://t.co/0qsZcihsHG pic.twitter.com/yZ37mfy624
NEW🔥 Review Article by @SIDPharm@BPotoski @davidantibiotic @padstamundo
— Antibiotic Steward (@ABsteward) February 5, 2019
Antimicrobial treatment challenges in the era of Carbapenem resistance https://t.co/kPYqp6rXdr pic.twitter.com/ktHkUXWx2j
NEW🔥🔥 @PharmacoJournal by Dr. Lina Meng and @StanDeresinski
— Antibiotic Steward (@ABsteward) February 10, 2019
Conversion from Vancomycin Trough Concentration–Guided Dosing to Area Under the Curve–Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center. https://t.co/o5KJPmgyuD pic.twitter.com/965XK1lkFJ
Delighted to announce 12 successful partnerships receiving funding through our Commonwealth Partnerships for Antimicrobial Stewardship project #CwPAMS 👏NHS teams are linking with coutnerparts in Uganda 🇺🇬, Ghana 🇬🇭, Tanzania 🇹🇿 and Zambia 🇿🇲 https://t.co/MS9zkHInDt #AidWorks pic.twitter.com/Br8suqIZfO
— The Fleming Fund (@FlemingFund) February 12, 2019
NEW🔥🔥 EPIC RCT published @NEJM Once-Daily Plazomicin for Complicated Urinary Tract Infections.https://t.co/ePXCz2Nfva
— Antibiotic Steward (@ABsteward) February 20, 2019
Check editorial
Needed: Antimicrobial Developmenthttps://t.co/LHBt8dZi6R pic.twitter.com/c5ENrmTYmf
👀 Therapeutic monitoring of #vancomycin revised consensus guideline available for public comment! Submit by March 15th. 🗓🖍‼️ @ASHPOfficial @IDSAInfo @PIDSociety @SIDPharm https://t.co/Tl4rZtFkZD
— Erin McCreary (@ErinMcCreary) February 20, 2019
🔥 off press!Twitter2engage, educate,global antibiotic stewardship &resistance Lancet ID @bnwomeh @eliowa @TheIDApprentice @SIDPharm @inspired2leadQH @Gary_An @JohnNosta @chngin_the_wrld https://t.co/SVvLpYBkW2
— Debbie Goff (@idpharmd) February 28, 2019
#MOOC #antimicrobialstewardship survey in @ARICJournal from 55 countries: we are not doing enough to train #pharmacists #nurses; surveillance of antibiotic use needs more focus; specialty level culture matters @HPRUamr https://t.co/8fGNDmXO9B
— Esmita Charani (@e_charani) February 13, 2019
NEW🔥Systematic Review & Meta-analysis @accpchest concluded that increased survival& decreased antibiotic utilization associated with PCT-guided antibiotic discontinuation in critically ill adults represent low certainty evidence with a high risk of bias. https://t.co/0ulCLZs1rg pic.twitter.com/1byyq1SlhD
— Antibiotic Steward (@ABsteward) February 15, 2019
80% of patients with a penicillin allergy record could be ‘de-labelled’, 80% were ‘de-labelled’ after an interview with a pharmacist alone https://t.co/eSD2tY5L7Y
— Jonathan Sandoe (@j_sandoe) February 12, 2019
NEW 🔥in @BSACandJAC Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital.
— Antibiotic Steward (@ABsteward) February 8, 2019
80% of study patients could be ‘de-labelled’. Of those, 80% were ‘de-labelled’ after an interview with the #Pharmacist alone.👍 #JACnews https://t.co/sDsDt6kZMg pic.twitter.com/vbhREpc1en
NEW🔥 in CID
— Antibiotic Steward (@ABsteward) February 13, 2019
Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
Results are 😱https://t.co/WB3fd6OOSO pic.twitter.com/9AqTmv2nYW
NEW🔥 in CID LEAP 1 Trial Published! Efficacy and Safety of IV-to-Oral Lefamulin, a Pleuromutilin Antibiotic, for Treatment of Community-Acquired Bacterial Pneumonia. https://t.co/4C1gLIiVTU pic.twitter.com/RGCTqmiAKJ
— Antibiotic Steward (@ABsteward) February 4, 2019
NEW🔥 pilot randomized controlled trial published in @accpchest
— Antibiotic Steward (@ABsteward) February 16, 2019
A highly-sensitive BAL RDT for MRSA significantly reduced use of vancomycin and linezolid in ventilated patients with suspected pneumonia. Thoughts 🤔https://t.co/GkMyo1VLYX pic.twitter.com/AZr5AJ5p1O
Excited for our article on the Impact of Discontinuation of Contact Precautions for MRSA/ VRE on CLABSIs in an Academic Children's Hospital in @ICHEJournal! 1st article showing no adverse effects on CLABSIs w/ CP d/c specifically in children @SHEA_Epi https://t.co/TDFGTYgKSn pic.twitter.com/kMXpqVaef0
— Mike Stevens (@Dr_Mike_Stevens) February 22, 2019
This is the reply from the author of the @IDSAInfo cdiff guidelines Dr. McDonald about evidence to support why Metronidazole is inferior to Vancomycin in mild( non severe) cdiff infection. https://t.co/MYOw1W6NHZ
— Antibiotic Steward (@ABsteward) February 9, 2019
We are extremely excited to announce 12 #healthpartnerships involving #NHS #pharmacists will receive funding from @FlemingFund@UKgovGHS to support #antimicrobialstewardship in #Ghana #Tanzania #Uganda #Zambia https://t.co/YIzuELsHUt
— CPA (@CW_Pharmacists) February 12, 2019
Just published by Journal of the Pediatric Infectious Diseases Society . . Quick, create hysteria, use pharma influence w/ financed legislators to mandate vaccines! Before people realize! https://t.co/F01v1GyKOX… pic.twitter.com/PaSkg9AKfC
— Plum Remson (@PlumRemson) February 26, 2019
Excellent review: Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria @cellhostmicrobe https://t.co/7jOdf9i4NG
— Laura Piddock (@LauraPiddock) February 18, 2019
Call open for Group Leaders of Junior Research Groups (G5) at @institutpasteur with focus on:
— Björn Meyer (@MeyerBjoern) February 1, 2019
Emerging infectious diseases,
Resistance to antimicrobial agents,
Brain connectivity and Neurodegenerative diseases.https://t.co/LnsCrfnsyR
So much talk about #OVIVA that I made up an "interview" (ahem) with this highly anticipated landmark study. H/T to @PhilipBejon here and Matthew Scarborough for input. Latest post: https://t.co/iH188Vud07
— Paul Sax (@PaulSaxMD) February 3, 2019
Researchers discover almost 2,000 new gut bacteria.
— Microbes&Infection (@MicrobesInfect) February 13, 2019
Human gut #microbiota is capable of influencing many aspects of our physical and mental health. But many bacteria remain "unmapped". A new study uncovered ~2,000 previously unknown gut bacteria.https://t.co/NDcQKsK1Iy pic.twitter.com/WxyedYhUyq
Thankfully most antibiotic courses are not chronic therapy, but 💊 medication adherence is critical to treatment success and an important topic for #abxstewardship #pharmacists
— Bug Pharmacist (@IDstewardship) February 13, 2019
New in @JACCPJournal via @ACCP 📲 https://t.co/t3KHSMv1IY pic.twitter.com/fJNVVOmN0w
Nigeria has been routinely battered by infectious diseases: meningitis, measles, cholera and newly emerging threats that plague communities and raise alarms around the world. @Chikwe_I’s @NCDCgov will stand in the way of the next contagion. https://t.co/n6FfL9kEfX
— nature (@nature) February 22, 2019
NEW🔥🔥 OPTIC RCT just published in @NEJM
— Antibiotic Steward (@ABsteward) February 6, 2019
Omadacycline was noninferior to moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults.https://t.co/aYqImCYfKS pic.twitter.com/ybvtplnDlw
NEW in CID 🔥🔥Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility? @hboucher3 @JasonGNewland https://t.co/IEMEw050GS pic.twitter.com/5N7gmUO5ky
— Antibiotic Steward (@ABsteward) February 1, 2019
New evidence links specific gut bacteria to depression.
— Microbes&Infection (@MicrobesInfect) February 5, 2019
Examining over 1,000 people, a new study revealed two bacteria in particular as being strongly associated with mood and #depression https://t.co/uyvDP6YCYk #microbiome #microbiota #behavior pic.twitter.com/hpYkh3b9b2
Presenting our #ASPIRES study on #antibiotic use in #surgery to a room full of surgeons in #Jaipur - only 3 people had heard of #antimicrobialstewardship 😱 We need better strategies to engage with other specialties https://t.co/fXFTamjPW8 @HPRUamr @ARC_at_Imperial @TmRawson pic.twitter.com/kvpvTMvA1c
— Esmita Charani (@e_charani) February 16, 2019
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.